Innovative Care for Digestive Disorders from New York’s #1 Hospital.
Our team of physicians and digestive care experts offer procedures, services, and facilities based on the latest medical advances that can be challenging to find elsewhere. One of the most experienced in the country, our program provides comprehensive care and a wide range of treatment options, all in one location.
Advancing Understanding and Management of Fatty Liver Disease
Gastroenterologists at NewYork-Presbyterian Hospital continue to characterize the biological mechanisms of non-alcoholic fatty liver disease, define best practices for its management, and pursue research to identify effective treatment options.
Lynch Syndrome: Reducing the Risk of Cancer with Genetic Precision
Comprehensive GI Clinical Cancer Genetics programs at NewYork-Presbyterian Hospital are furthering understanding of inherited cancer syndromes such as Lynch syndrome to facilitate early screening and prevent the development of colorectal cancer.
Spearheading Advances in Bariatric Surgery
Comprehensive and collaborative bariatric surgery and weight management programs at NewYork-Presbyterian Hospital are providing integrated care by endocrinologists and surgeons, helping patients achieve significant and durable weight loss and improve overall health.
Tackling Treatment Challenges in IBD
Columbia and Weill Cornell gastroenterologists and GI surgeons are advancing the care of inflammatory bowel disease, including pouch disorders, though new program initiatives and research that span a range of investigations from the laboratory to the clinic to further development of effective therapies.
Revealing the Role of Stem Cells in Gut Regeneration
Studies of intestinal stem cells are shedding light on the mechanisms of gut regeneration. A physician-scientist at NewYork-Presbyterian/
A New Pancreatitis Program: Comprehensive Care for Progressive Pancreatic Disease
Given our experience and the enormous volume of patients with pancreatic disease that we see here at Columbia, we felt that it was valuable to formalize our treatment of these patients with a full-service program.
A Long and Winding Road: Scoping Out Uncharted Territory in the Colon
The DiLumen Endolumenal Interventional Platform (EIP) developed at NewYork-Presbyterian/
Pancreatic Cysts: When Is There a Cause for Concern?
The Pancreatic Cyst Surveillance Program at NewYork-Presbyterian/
Fecal Transplant: An Old Remedy Made New
While the use of fecal material as a medical remedy dates back to the fourth century, usage waned. In recent years, fecal microbiota transplant to control multiple relapses of Clostridium difficile infections is rising.
Proton Pump Inhibitors: The Risk-Benefit Equation
Proton pump inhibitors (PPIs) have become one of the top oral medications in the United States. With the rise of use, clinicians and researchers at NewYork-Presbyterian/
Newsletters for Medical Professionals
2022 Issue 2
2022 Issue 1
2021 Issue 3
2021 Issue 2
2021 Issue 1
2020 Issue 1
- Dr. Bo Shen: Leading the Way in IBD and Pouch Disorders
- Innovative Center Addresses GI Complications of Obesity
- Redefining Selection Policies for HCC Liver Transplantation
- A New Pancreatitis Program: Comprehensive Care for Progressive Pancreatic Disease
- Major Faculty Expansion in Gastroenterology and GI Surgery
- Research Highlights: Targeting Challenges in Digestive Disease
- A Long and Winding Road: Scoping Out Uncharted Territory in the Colon
- Revealing the Role of Stem Cells in Gut Regeneration
- Pancreatic Cysts: When Is There a Cause for Concern?
- Fecal Microbiota Transplant: An Old Remedy Made New
- Mobile Health Technology: Tracking Postop Recovery to Improve Outcomes
- Proton Pump Inhibitors: The Risk-Benefit Equation
- Motility Disorders: A Comprehensive Management Approach
- NAFLD Research: Making Progress on Many Fronts